Abstract |
The activity of three pyrroles and four pyrrolizines is compared in several different experimental leukemias and solid tumors in mice. Two compounds were particularly noteworthy, the bis(N-cyclohexylcarbamate) and the bis[N-(2-propyl)] derivatives of 2,3-dihydro-5-(3,4-dichlorophenyl)-6,7-bis(hydroxymethyl)-1H-pyrrolizine. These two compounds showed a very high level of activity against B16 melanocarcinoma, CD8F1 mammary tumor, colon tumor 26, and colon tumor 38, and a significant number of "cures" were recorded. The isopropyl compound was more potent than the cyclohexyl compound, but both showed a similar profile of activity.
|
Authors | W K Anderson, C P Chang, P F Corey, M J Halat, A N Jones, H L McPherson Jr, J S New, A C Rich |
Journal | Cancer treatment reports
(Cancer Treat Rep)
Vol. 66
Issue 1
Pg. 91-7
(Jan 1982)
ISSN: 0361-5960 [Print] United States |
PMID | 7053273
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
|
Topics |
- Animals
- Drug Evaluation, Preclinical
- Leukemia, Experimental
(drug therapy)
- Male
- Mice
- Neoplasms, Experimental
(drug therapy)
- Pyrroles
(therapeutic use)
- Pyrrolidines
(therapeutic use)
- Structure-Activity Relationship
|